Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 72))

  • 81 Accesses

Abstract

Dopamine is a catecholamine with significant inotropic activity, peripheral vasoconstricting activity and, at low concentrations, also renal vasodilating activity [1]. It is widely used for cardiocirculatory support in cases of shock and severe resistant congestive heart failure. Dopamine increases cardiac output, stroke volume, heart rate, systemic vascular resistance, and arterial pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McNay JL, et al: Direct renal vasodilatation produced by dopamine in the dog. Circ Res 16:510, 1965.

    PubMed  CAS  Google Scholar 

  2. Loeb HS, et al: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55:375, 1977.

    PubMed  CAS  Google Scholar 

  3. Francis GS, et al: Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 103:995, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Leier CV, Unverferth DV: Diagnosis and treatment. Drugs five years later: dobutamine. Am J Physicians 99:490, 1983.

    CAS  Google Scholar 

  5. Boltax RS, et al: Gangrene resulting from infiltrated dopamine solution. N Engl J Med 296:823, 1977.

    PubMed  CAS  Google Scholar 

  6. Alexander CS, et al: Pedal gangrene associated with the use of dopamine. N Engl J Med 293:591, 1975.

    Article  PubMed  CAS  Google Scholar 

  7. Greene SI, Smith JW: Dopamine gangrene. N Engl J Med 294:114, 1976.

    Article  PubMed  CAS  Google Scholar 

  8. Greenlaw CW, Mull LW: Dopamine induced ischemia. Lancet 2:555, 1977.

    Article  PubMed  CAS  Google Scholar 

  9. Goldberg LI: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 24:1, 1972.

    PubMed  CAS  Google Scholar 

  10. Ebels T, Homan van der Heide JN: Dopamine induced ischemia. Lancet 2:762, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Maggi JC, et al: Gangrene in a neonate following dopamine therapy. J Pediatr 100:325, 1982.

    Article  Google Scholar 

  12. Valdex ME: Post-dopamine ischemia treated with chlorpromazine. N Engl J Med 295:1081, 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Schneeweiss, A., Schettler, G. (1988). Dopamine. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2063-0_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9225-8

  • Online ISBN: 978-1-4613-2063-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics